Compare · NBIS vs TEM
NBIS vs TEM
Side-by-side comparison of Nebius Group N.V. (NBIS) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NBIS and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $60.34B, about 4.9x TEM ($12.40B).
- TEM has been more active in the news (20 items in the past 4 weeks vs 19 for NBIS).
- TEM has more recent analyst coverage (25 ratings vs 18 for NBIS).
- Company
- Nebius Group N.V.
- Tempus AI Inc.
- Price
- -
- -
- Market cap
- $60.34B
- $12.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2011
- 2024
- News (4w)
- 19
- 20
- Recent ratings
- 18
- 25
Latest NBIS
- Nebius Group N.V. announces results of its Annual General Meeting
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $5.75 billion
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces pricing of upsized private offering of $5.0 billion of convertible senior notes
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces proposed private offering of $4.50 billion of convertible senior notes
- Director Ryan Charles E sold $13,276,633 worth of Class A Shares (50,000 units at $265.53), decreasing direct ownership by 16% to 272,533 units (SEC Form 4)
- Director Boynton John Wilson Iv sold $1,435,147 worth of Class A Shares (5,296 units at $270.99), decreasing direct ownership by 1% to 415,844 units (SEC Form 4)
- Vantage Data Centers and Nebius Expand UK AI Infrastructure with First Deployment in South Wales AI Growth Zone
Latest TEM
- SEC Form 144 filed by Tempus AI Inc.
- CEO, Diagnostics Schoenherr Thomas Edward increased direct ownership by 3% to 87,021 units (SEC Form 4)
- CEO, Data Fukushima Ryan sold $1,000,020 worth of shares (14,286 units at $70.00) as part of a pre-agreed trading plan (SEC Form 4)
- Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
- CEO, Diagnostics Schoenherr Thomas Edward sold $929,990 worth of shares (17,314 units at $53.71) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 89,715 units (SEC Form 4) (for withholding tax)
- CEO and Chairman Lefkofsky Eric P sold $6,577,840 worth of shares (132,591 units at $49.61), decreasing direct ownership by 6% to 2,098,130 units (SEC Form 4) (for tax liability)
- CEO, Data Fukushima Ryan sold $2,038,723 worth of shares (41,095 units at $49.61), decreasing direct ownership by 7% to 562,463 units (SEC Form 4) (withholding obligation)
- Chief Financial Officer Rogers James William sold $2,696,444 worth of shares (48,842 units at $55.21) as part of a pre-agreed trading plan, decreasing direct ownership by 32% to 106,024 units (SEC Form 4) (tax liability)
- EVP, Chief Legal Officer Polovin Andrew sold $1,542,674 worth of shares (30,075 units at $51.29) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 138,140 units (SEC Form 4) to satisfy tax liability
- Chief Accounting Officer Bartolucci Ryan M sold $306,342 worth of shares (6,175 units at $49.61), decreasing direct ownership by 8% to 67,866 units (SEC Form 4) (tax liability)